ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$32.88
−0.12%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$1.22
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$1.77
- EPS estimate
- -$1.12
- Revenue actual
- $1.0M
- Revenue estimate
- $15.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -114.5%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $44
- PT range
- $32 – $55
- Analysts
- 3
2 Buy1 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 12, 2027